Funded Tech Companies
Antag Therapeutics
Researching who provided funding to Antag Therapeutics? SR One Capital Management, Longview International and EIFO put venture money into this life sciences company.
Company Overview
Company Name
Antag Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
COBIS Ole Maaløes Vej 3
Copenhagen, 2200
Denmark
Copenhagen, 2200
Denmark
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Antag Therapeutics is a biotechnology company dedicated to developing innovative peptide-based therapies to address obesity and related cardiometabolic disorders. Our approach is rooted in decades of pioneering research from the University of Copenhagen, with a focus on the complexities of incretin physiology.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/4/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexander Sparre-Ulrich
Chief Financial Officer
Jakob Hansen
Chief Medical Officer
Richard Nkulikiyinka
Chief Scientific Officer
Mads Christensen
Vice President
Ingrid Bøgh
VP - Operations
John Boland
VP - Regulatory Affairs
Sandra Cottrell
Company Investors
- SR One Capital Management
- Longview International
- EIFO
- Versant Ventures
- Dawn Biopharma
- Novo Holdings
Browse more funded tech companies:
Antabio | Antares Advanced Test Technologies
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs